Sun Pharmaceutical Industries Ltd Share Price
(SUNPHARMA)
₹1824.5
as on 11:22AM, 29 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 8.43 % |
3 Month Return | + 6.12 % |
1 Year Return | + 21.03 % |
Market Stats | |
Previous Close | ₹1,841.60 |
Open | ₹1,826.00 |
Volume | 7.11L |
Upper Circuit | ₹2,025.70 |
Lower Circuit | ₹1,657.50 |
Market Cap | ₹4,41,861.53Cr |
P/E Ratio
38.61
PEG Ratio
3.64
Market Cap
₹4,41,861.53 Cr
P/B Ratio
16.41
EPS
40.21
Dividend Yield
0.83
Sector
Pharmaceuticals
ROE
12.05
based on 37 analysts
81.08%
Buy
10.81%
Hold
8.11%
Sell
Based on 37 analysts offering long term price targets for Sun Pharma. An average target of ₹2047.89
Source: S&P Global Market Intelligence
Sun Pharma price forecast by 37 analysts
Upside of11.20%
High
₹2450
Target
₹2047.89
Low
₹1500
Sun Pharma target price ₹2047.89, a slight upside of 11.2% compared to current price of ₹1824.5. According to 37 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Sun Pharma revenue growth forecast
Expected growth rate Q1, FY2027:32.23%
Forecast
Actual
Including amortisation and stock based compensations
Sun Pharma EPS growth forecast
EPS estimate Q1, FY2027:56.55%
Forecast
Actual
Source: S&P Global Market Intelligence
Sun Pharma Reports Positive Osteoarthritis Drug Trial Results - 24 Apr, 2025
Sun Pharma Anticipates Strong US Market Growth - 23 Apr, 2025
Sun Pharma Shares Rise with Buy Recommendation - 20 Apr, 2025
Sun Pharma Faces Recall Amid Regulatory Challenges - 14 Apr, 2025
Sun Pharma Faces Recall Amid Stock Recovery - 13 Apr, 2025
Sun Pharma Gains Court Approval for Leqselvi Launch - 10 Apr, 2025
Sun Pharma Faces Challenges from US Tariff Announcement - 09 Apr, 2025
Sun Pharma Launches New Drug Amid Market Challenges - 07 Apr, 2025
Sun Pharma Faces Tariff Concerns Amid Growth Prospects - 04 Apr, 2025
Sun Pharma Shares Surge on Tariff Exemption News - 03 Apr, 2025
Sun Pharma Reports Strong Growth Amid Challenges - 02 Apr, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, SUNPHARMA stock has moved up by 5.4%
Revenue Rich
Revenue is up for the last 4 quarters, 12.58K Cr → 14.14K Cr (in ₹), with an average increase of 3.8% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 30.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.48% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 38.7%
FII Holding Down
Foreign Institutions have decreased holdings from 18.05% to 17.96% in Mar 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 8.92% to 8.87% in Mar 2025 quarter
MF Holding Down
Mutual Funds have decreased holdings from 12.24% to 12.21% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 3.04K Cr → 2.90K Cr (in ₹), with an average decrease of 4.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.48% | 0.00 | |
Foreign Institutions | 17.96% | 0.00 | |
Mutual Funds | 12.21% | 0.00 | |
Retail Investors | 8.87% | 0.00 | |
Others | 6.48% | 0.00 |
Sun Pharma in the last 5 years
Lowest (19.47x)
March 23, 2020
Today (38.61x)
April 28, 2025
Industry (53.89x)
April 28, 2025
Highest (184.63x)
August 28, 2020
Sun Pharmaceutical Industries Ltd’s net profit jumped 15.04% since last year same period to ₹2,903.38Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -4.5% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2024, Sun Pharmaceutical Industries Ltd has declared dividend of ₹10.50 - translating a dividend yield of 1.30%.
Read More about DividendsBearish
Neutral
Bullish
Sun Pharmaceutical Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,41,861.53 Cr | 57.11% | 0.68 | ₹9,648 Cr | ₹48,496 Cr | |
HOLD | ₹1,59,984.64 Cr | 30.86% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,12,866.49 Cr | 35.12% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
BUY | ₹38,521.25 Cr | -1.78% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹23,281.73 Cr | -4.47% | 0.50 | ₹772 Cr | ₹5,664 Cr |
Organisation | Sun Pharma |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Sun Pharmaceutical Industries Ltd share price today stands at ₹1824.5, Open: ₹1826, Previous Close: ₹1841.6, High: ₹1846, Low: ₹1811, 52 Week High: ₹1960.35, 52 Week Low: ₹1377.2.
Today's traded volume of Sun Pharmaceutical Industries Ltd(SUNPHARMA) is 7.11L.
Today's market capitalisation of Sun Pharmaceutical Industries Ltd(SUNPHARMA) is ₹441861.53Cr.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) share price is ₹1824.5. It is down -6.93% from its 52 Week High price of ₹1960.35
Sun Pharmaceutical Industries Ltd (SUNPHARMA) share price is ₹1824.5. It is up 32.48% from its 52 Week Low price of ₹1377.2